We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $801M
1-Year Est. Return 23.14%
This Fund
S&P 500
This Quarter Est. Return
-14.43%
1 Year Est. Return
+23.14%
3 Year Est. Return
+51.97%
5 Year Est. Return
+52.71%
10 Year Est. Return
+183.03%
AUM
$936M
AUM Growth
-$16M
Cap. Flow
+$194M
Cap. Flow %
20.74%
Top 10 Hldgs %
68.34%
Holding
41
New
9
Increased
11
Reduced
6
Closed
8
Avg Time Held Equity + Options
6.4 quarters
Top 10 Avg Time Held Equity + Options
3.5 quarters
Top 20 Avg Time Held Equity + Options
6.3 quarters
Avg Time Held Equity only
6.4 quarters
Top 10 Avg Time Held Equity only
3.5 quarters
Top 20 Avg Time Held Equity only
6.6 quarters

Top Buys

Rank Stock Value
1
PAR icon
PAR Technology
PAR
+$54.2M
2
USAR icon
USA Rare Earth Inc
USAR
+$45.4M
3
TFX icon
Teleflex
TFX
+$44.1M
4
WEAV icon
Weave Communications
WEAV
+$40.8M
5
QDEL icon
QuidelOrtho
QDEL
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 35.73%
2 Industrials 18.82%
3 Technology 11.21%
4 Communication Services 11.19%
5 Real Estate 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NVRI icon
1
Enviri
NVRI
$576M
$108M 11.54%
5,502,200
+902,813
+20% +$16.8M
2025 Q2
3 quarters
TBPH icon
2
DELISTED
Theravance Biopharma
TBPH
$78.6M 8.4%
4,841,629
+541,629
+13% +$9.58M
2021 Q3
18 quarters
QDEL icon
3
QuidelOrtho
QDEL
$967M
$74.9M 8%
4,558,472
+1,543,877
+51% +$37.9M
2024 Q2
7 quarters
AD icon
4
Array Digital Infrastructure
AD
$2.91B
$74.6M 7.97%
1,616,856
-83,144
-5% -$4.14M
2025 Q3
2 quarters
VISN icon
5
Vistance Networks Inc
VISN
$1.41B
$68.5M 7.32%
3,762,713
+1,543,886
+70% +$28.2M
2025 Q3
2 quarters
INDV icon
6
Indivior Pharmaceuticals
INDV
$4.18B
$61M 6.51%
2,000,000
-534,538
-21% -$17.7M
2024 Q3
6 quarters
AIV icon
7
Aimco
AIV
$251M
$49.7M 5.31%
12,200,000
+3,002,675
+33% +$15.7M
2023 Q3
10 quarters
TFX icon
8
Teleflex
TFX
$5.27B
$47.8M 5.11%
+400,000
New +$44.1M
2026 Q1
0 quarters
RHLD icon
9
Resolute Holdings Management
RHLD
$928M
$39.3M 4.2%
242,423
– –
2025 Q2
3 quarters
CNNE icon
10
Cannae Holdings
CNNE
$682M
$37.1M 3.97%
3,266,955
-281,554
-8% -$3.78M
2022 Q2
15 quarters
PAR icon
11
PAR Technology
PAR
$665M
$36.4M 3.89%
2,732,696
+2,307,767
+543% +$54.2M
2022 Q1
16 quarters
USAR icon
12
USA Rare Earth Inc
USAR
$4.23B
$35.4M 3.78%
+2,339,613
New +$45.4M
2026 Q1
0 quarters
WEAV icon
13
Weave Communications
WEAV
$593M
$32.3M 3.46%
+7,000,000
New +$40.8M
2026 Q1
0 quarters
CCOI icon
14
Cogent Communications
CCOI
$439M
$30.1M 3.22%
1,600,000
+200,000
+14% +$4.41M
2024 Q1
8 quarters
MAGN icon
15
Magnera Corp
MAGN
$395M
$26.2M 2.8%
2,760,000
+400,000
+17% +$5.11M
2024 Q3
6 quarters
BV icon
16
BrightView Holdings
BV
$1B
$24.8M 2.65%
2,100,000
– –
2024 Q2
7 quarters
CMP icon
17
Compass Minerals
CMP
$975M
$18M 1.92%
770,000
-52,817
-6% -$1.24M
2025 Q2
3 quarters
SPB icon
18
Spectrum Brands
SPB
$1.77B
$13.6M 1.46%
185,012
-64,925
-26% -$4.63M
2018 Q3
30 quarters
RCKT icon
19
Rocket Pharmaceuticals
RCKT
$252M
$11.3M 1.21%
3,165,900
+515,900
+19% +$2.05M
2025 Q2
3 quarters
FLWS icon
20
1-800-Flowers.com
FLWS
$166M
$10.6M 1.14%
3,500,000
– –
2025 Q2
3 quarters
DXYZ icon
21
Destiny Tech100
DXYZ
$917M
$9.24M 0.99%
+345,000
New +$9.95M
2026 Q1
0 quarters
NODK icon
22
NI Holdings
NODK
$303M
$8.64M 0.92%
670,000
– –
2017 Q1
36 quarters
RARE icon
23
Ultragenyx Pharmaceutical
RARE
$1.47B
$8.38M 0.9%
400,000
+104,085
+35% +$2.34M
2025 Q4
1 quarter
GRAL icon
24
GRAIL Inc
GRAL
$6.27B
$7.75M 0.83%
150,000
– –
2024 Q2
7 quarters
ATAI icon
25
DELISTED
AtaiBeckley Inc
ATAI
$6.31M 0.67%
+1,781,703
New +$6.71M
2026 Q1
0 quarters

Similar funds

Newtyn Management's Q1 2026 Portfolio in Review

As of Q1 2026, Newtyn Management held 41 positions worth $936M, down 1.7% from $952M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Newtyn Management deployed $194M of net new capital in Q1 2026, opening 9 new positions and adding to 11 existing holdings. Its largest new stake was USA Rare Earth Inc: 2,339,613 shares worth $35.4M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 36% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Indivior Pharmaceuticals, an estimated $17.7M trimmed.

  • Newtyn Management's largest Q1 2026 buy was USA Rare Earth Inc: 2,339,613 shares worth $35.4M.
  • Newtyn Management added most to PAR Technology in Q1 2026, an estimated $54.2M increase.
  • Newtyn Management's biggest Q1 2026 reduction was Indivior Pharmaceuticals, cutting an estimated $17.7M.
  • Newtyn Management fully exited Integer Holdings in Q1 2026, selling an estimated $43.1M.
  • Newtyn Management's ten largest holdings make up 68% of its $936M portfolio in Q1 2026.
  • Newtyn Management opened 9 new positions and closed 8 in Q1 2026.
  • Newtyn Management's portfolio value fell 1.7% quarter-over-quarter to $936M.

Based on Newtyn Management's 13F filing for Q1 2026, filed 15 May 2026.